What's proven, what's promising, and what women should know.
Peptides seem to be everywhere. From longevity clinics and wellness podcasts to social media, they're being promoted for everything from weight loss and injury recovery to healthier skin, better sleep, and slower aging.
The conversation recently reached The Atlantic, whose December 2026 issue features Tom Bartlett's “Mr. Peptide”, an examination of BPC-157 and the extraordinary claims surrounding this experimental compound.
It prompted our team at E Squared Health to look more closely at the science. Which peptides have demonstrated meaningful health benefits? Which remain experimental? And what should women know before considering them?
The answers are nuanced. Some peptide-based medications have transformed medical care. Others are attracting attention well ahead of the clinical evidence.
The question isn't whether peptides work. It's which ones work, for whom, and with what evidence of safety.
What are peptides, and why the excitement?
Peptides are short chains of amino acids, the building blocks of proteins. Many occur naturally in the body, helping regulate appetite, metabolism, hormone signaling, inflammation, and other essential functions.
Some are already established medicines and FDA approved. Insulin has treated diabetes for more than a century, while newer GLP-1-based medications, including semaglutide and tirzepatide, have demonstrated significant benefits in weight management and, for certain patients, cardiovascular risk reduction with other far ranging benefits currently being discovered.
These medications have undergone extensive clinical testing, with defined indications, dosing, and safety monitoring.
But the term peptide therapy now encompasses everything from FDA-approved prescriptions to experimental compounds promoted for recovery, performance, and longevity.
The success of one peptide does not validate another.
What's proven, and what's still experimental?
Several peptides generating attention in wellness and longevity circles have intriguing biological mechanisms. Yet for many, human clinical evidence remains limited or absent.
BPC-157 and TB-500: Injury recovery and tissue repair
These compounds are promoted for healing muscles, tendons, ligaments, and other tissues, largely on the strength of laboratory and animal studies.
An October 2026 systematic review of BPC-157 identified just three small human studies involving 30 participants. The researchers rated the certainty of evidence as very low. Reliable conclusions about effectiveness, appropriate dosing, and long-term safety remain out of reach.
TB-500, a peptide fragment associated with thymosin beta-4, faces similar evidence gaps. Findings about the full thymosin beta-4 molecule cannot automatically be applied to TB-500.
CJC-1295 and related peptides: Muscle and growth hormone
These compounds are promoted for muscle maintenance, recovery, and improved body composition. Some stimulate growth hormone release, but increased hormone levels do not necessarily translate into improved strength, physical function, or longevity.
Their longer-term metabolic and hormonal effects remain insufficiently understood.
GHK-Cu: Skin and collagen
This naturally occurring copper-binding peptide has attracted interest for its potential role in skin repair and collagen production. Early research is encouraging enough to warrant further investigation, particularly in dermatology.
However, evidence for topical cosmetic applications does not establish the safety or effectiveness of injectable treatments.
MOTS-c: Metabolism and longevity
This experimental peptide is being studied for its possible effects on cellular metabolism and mitochondrial function. Most evidence remains preclinical, and claims that it can extend human healthspan have not been established.
Across these examples, one distinction is essential: a promising biological mechanism is not proof of a meaningful clinical benefit.
Why this matters for women's health
For women navigating midlife and beyond, the appeal of peptides is understandable.
Changes in hormonal signaling, body composition, muscle mass, metabolism, sleep, and skin often occur together. Many experimental peptide therapies are marketed as potential solutions to precisely these concerns.
But similar symptoms can have very different underlying causes.
Fatigue may reflect disrupted sleep, hormonal changes, thyroid dysfunction, nutritional deficiencies, or other conditions. Changes in muscle strength or body composition may involve hormone fluctuations, physical activity, medications, or metabolic health.
Treating a symptom without understanding its cause can overlook a more appropriate—and better-established—intervention.
There is also a significant research gap. For many experimental peptides, we lack adequate human studies, particularly research examining safety and effectiveness.
For women, the question isn't simply whether a treatment shows promise. It's whether the evidence applies to their individual health circumstances.
Safety: What we know, and what we don't
Peptide safety involves more than the molecule itself. How a product is manufactured, supplied, stored, and administered also matters.
Unlike FDA-approved medications, experimental peptides may lack standardized dosing, adequate human safety studies, or reliable information about interactions and long-term effects.
Products purchased through unregulated channels can also raise concerns about purity, potency, sterility, and contamination.
US policy concerning the compounding of certain experimental peptides is evolving. Changes in access or enforcement should not be confused with FDA approval or evidence of clinical benefit. Compounded medications are not themselves FDA-approved.
A clinician's prescription or a product labeled "research grade" does not independently establish that a treatment is safe or effective.
Not yet known to be harmful is not the same as shown to be safe.
Five questions to ask before considering a peptide
Whether a peptide is being recommended for recovery, metabolic health, skin changes, or longevity, informed decisions begin with a few essential questions.
What exactly is being recommended? Identify the specific peptide and its intended purpose. Evidence for one compound or condition may not apply to another.
What does the human evidence show? Look for well-designed clinical trials demonstrating meaningful benefits, not simply laboratory findings or testimonials.
Is it FDA-approved for this use? If not, understand its investigational and regulatory status, including how it is manufactured and supplied.
What are the risks and unknowns? Ask about side effects, interactions, dosing, and long-term safety.
Is it appropriate for my health history? Consider age, hormonal status, existing conditions, medications, and whether better-established alternatives are available.
Expert discussions, including those by physicians Peter Attia and Andrew Huberman, can help explain the evolving science. But podcasts and personal experiences, however compelling, are not substitutes for rigorous clinical evidence or individualized medical guidance.
The bottom line: Promise deserves proof
Peptides represent an important and evolving area of medicine. Their potential extends beyond today's approved treatments, and continued research may lead to meaningful advances in metabolic health, tissue repair, and the biology of aging.
But enthusiasm should not be mistaken for evidence.
For women, informed decisions require more than understanding what a molecule might do. They require considering the full context of individual health, medical history, and the quality of the research supporting a treatment.
At E Squared Health, we believe informed health decisions begin with credible evidence, clinical context, and a clear understanding of what science knows—and what it has yet to establish.
Peptides may be part of the future of medicine. Being informed is the best place to begin.
Sources and Further Reading
Peer-reviewed research
Human Evidence for BPC-157 in Orthopaedic and Regenerative Medicine - Acta Orthopaedica Belgica, October 2026. Systematic review finding very low-certainty human evidence.
Investigational Peptides in Orthopaedic Practice - Journal of the American Academy of Orthopaedic Surgeons, October 2026. Review of BPC-157, thymosin beta-4, and TB-500.
Once-Weekly Semaglutide in Adults with Overweight or Obesity - New England Journal of Medicine, 2021. Landmark randomized trial establishing substantial weight-loss benefits.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes - New England Journal of Medicine, 2023. SELECT trial demonstrating cardiovascular benefits in a defined patient population.
Regulatory guidance
FDA: Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks - FDA information on safety concerns and evidence limitations involving certain experimental peptides. Regulatory classifications may change.
Expert perspectives
Peter Attia, MD — Peptides - Discussion of scientific promise, clinical evidence, and marketing claims.
Andrew Huberman, PhD, with Abud Bakri, MD — Peptides: The Science, Uses & Safety - Discussion of peptide mechanisms, potential applications, and safety.
Atria Health Library — The Real Science of Peptides for Longevity - Reviewed by David W. Dodick, MD.
Decoding Women's Health with Dr. Elizabeth Poynor - Atria's broader women's health podcast series.
In the media
Tom Bartlett — “Mr. Peptide” / “Is There Anything BPC-157 Can't Cure?” - The Atlantic, December 2026 issue.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The evidence and regulatory status of peptide therapies continue to evolve. Consult a qualified healthcare professional familiar with your medical history before considering peptide treatments.